National Institutes of Health to Grant Exclusive Patent License for Gene Therapy for Ocular Disease

Summary

The National Institutes of Health is considering granting an exclusive patent license to OcQuila Therapeutics Ltd. for using the inventions covered by a specific patent, related to gene therapy for ocular diseases.